Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

238
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
238
Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

384
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence of...
384
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

246
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
246
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

519
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
519
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

314
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
314
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

488
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
488

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hairyvein agrimony-derived nanovesicles in microneedles eradicate intracellular bacteria and reverse senescence to heal diabetic foot osteomyelitis.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Scalable Cr(III) Passivation Engineering for Effectively Suppressing Zinc Escape Toward Practical Ah-Level Aqueous Zinc-Ion Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

A multi-strain biofilm consortium enhances gut microbiota resilience and restores post-antibiotic homeostasis.

World journal of microbiology & biotechnology·2026
Same author

An HOCl-activated chemiluminescent prodrug enabling self-reporting camptothecin release and imaging-guided therapy in peritoneal metastasis.

Bioorganic & medicinal chemistry·2026
Same author

IR783-enabled thioketal-bridged paclitaxel nanoprodrugs with ROS-responsive release for tumor imaging and chemotherapy.

Journal of photochemistry and photobiology. B, Biology·2026
Same author

Enhancing Exercise Performance Under Hypoxia: A Network Meta-Analysis and Animal Experimental Validation of Plant Bioactive Compounds.

Nutrients·2026

Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Variational Bayesian Multi-Output Gaussian Process Regression for Metabolic Profiles Prediction With Microbiome Data.

Qinghui Weng, Mingyi Hu, Guohao Peng

    IEEE Transactions on Computational Biology and Bioinformatics
    |January 12, 2026
    PubMed
    Summary

    This study introduces Variational Bayesian Multi-Output Gaussian Process Regression (VBMOGPR) for accurate human microbiome metabolite prediction. This method enhances understanding of the gut microbiome

    More Related Videos

    A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
    09:52

    A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

    Published on: January 10, 2025

    1.2K
    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
    05:01

    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

    Published on: July 1, 2020

    3.7K

    Related Experiment Videos

    Last Updated: Jan 14, 2026

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    2.0K
    A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
    09:52

    A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

    Published on: January 10, 2025

    1.2K
    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
    05:01

    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

    Published on: July 1, 2020

    3.7K

    Area of Science:

    • Microbiology
    • Bioinformatics
    • Computational Biology

    Background:

    • The human microbiome plays a critical role in health.
    • Accurate prediction of microbial metabolites is essential for understanding the gut microbiome's impact on human health.
    • Existing methods face challenges with complex, high-dimensional microbiome data.

    Purpose of the Study:

    • To introduce an innovative approach for predicting microbial metabolites.
    • To quantify model confidence and incorporate uncertainty estimates in predictions.
    • To enhance the interpretability and performance of microbiome data analysis.

    Main Methods:

    • Development and application of Variational Bayesian Multi-Output Gaussian Process Regression (VBMOGPR).
    • Utilizing a Bayesian framework with Automatic Relevance Determination (ARD) for feature selection.
    • Comparative analysis across 14 datasets within a meta-database.

    Main Results:

    • VBMOGPR demonstrates superior performance in metabolite prediction compared to existing methods.
    • The model effectively quantifies prediction confidence and incorporates uncertainty.
    • Feature selection via ARD improved model interpretability and performance.
    • Confirmed VBMOGPR's capability to identify potential microbial metabolic associations.

    Conclusions:

    • VBMOGPR represents a significant advancement in microbial metabolite prediction.
    • The method offers enhanced understanding of the microbiome's role in human health.
    • VBMOGPR provides a robust tool for exploring microbial metabolic associations.